Phenytoin Tablet, Chewable
Product Images NDC 64980-573

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Phenytoin (NDC 64980-573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Phenytoin-100ct (Phenytoin 100ct)

Phenytoin-100ct (Phenytoin 100ct)
This is a product label for Phenytoin, which is a type of medication used to treat seizures. The provided information includes the National Drug Code (NDC) number 64980-673-01, the drug name "Phenytoin," the pharmaceutical form "Chewable Tablets, USP," and the quantity "100 Tablets."*
FDA Label Image

Phenytoin-struc (Phenytoin Struc)

Phenytoin-struc (Phenytoin Struc)
FDA Label Image

Phenytion-table1 (Phenytoin Table1)

Phenytion-table1 (Phenytoin Table1)
This description presents a table outlining the risk associated with antiepileptic drugs based on different indications in a pooled analysis. The table includes information such as the number of events per 1000 patients for both placebo and drug patients, the relative risk of events in drug patients compared to placebo patients, and the risk difference. The indications listed in the table are epilepsy, psychiatric conditions, and other conditions.*
FDA Label Image

Phenytoin-table2 (Phenytoin Table2)

Phenytoin-table2 (Phenytoin Table2)
This text provides a detailed list of drugs that can affect phenytoin concentrations in the body. It categorizes drugs that may increase phenytoin serum levels into groups like antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, and others. It also includes drugs that may decrease phenytoin serum levels, such as antacids, antineoplastic agents, antiviral agents, and other medications like chronic alcohol abuse and folic acid. Additionally, the text mentions drugs that may either increase or decrease phenytoin serum levels, mainly focusing on antiepileptic drugs like phenobarbital, valproate sodium, and valproic acid. It also gives preventive or management advice that phenytoin and antacids should not be taken at the same time of day to avoid interactions.*
FDA Label Image

Phenytoin-table3 (Phenytoin Table3)

Phenytoin-table3 (Phenytoin Table3)
Table 3 provides a list of drugs that are affected by Phenytoin, a medication commonly used to treat seizures. Phenytoin can impact the efficacy of various drugs such as azoles, antineoplastic agents, delavirdine, neuromuscular blocking agents, warfarin, corticosteroids, anticoagulants, antiepileptic drugs, antilipidemic agents, antiplatelets, and antiviral agents. For some drugs, the levels may be decreased or increased when coadministered with Phenytoin. Monitoring and careful management are essential to ensure optimal treatment outcomes when using Phenytoin alongside these medications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.